1887

Journal of General Virology header logo

Volume 80, Issue 11

Human immunodeficiency virus infection activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein Free

Abstract

Human papillomavirus (HPV) infections are prevalent in human immunodeficiency virus (HIV)-positive individuals. To highlight the effect of HIV on HPV expression, HPV-18-positive HIV-permissive HeLa-T4 cells were either infected with HIV-1 or treated with Tat or with the cytokines IL-1α, IL-1β, IL-6 and TNF-α . The presence of HPV-18 E1 (early) and L1 (late) transcripts was then determined by dot-blot or Northern blot hybridization with E1 and L1 or with genomic HPV-18 DNA probes, respectively. Protein extracts from parallel cultures were challenged by Western blotting with an antiserum raised against an L1–β-galactosidase hybrid protein. Results indicated that HeLa-T4 cells constitutively express E1 and L1 transcripts. When cells were infected with HIV, the amounts of E1 and L1 RNAs increased with time, followed by the appearance of L1 protein. E1 and L1 transcripts were also increased, in a dose-dependent manner, by treatment of uninfected cultures with Tat or with IL-6, but were not affected by IL-1α, IL-1β and TNF- α. Neither Tat nor IL-6 could induce L1 translation. These findings raise the hypothesis that the increase of HPV shedding and of HPV-associated diseases in HIV-infected individuals could be due in part to a direct or cytokine-mediated action of HIV, in addition to the HIV-induced immunodeficiency.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-11-2937
1999-11-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/11/0802937a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-11-2937&mimeType=html&fmt=ahah

References

  1. Arany I., Yen A., Tyring S. K. 1997; p53, WAF1/CIP1 and mdm2 expression in skin lesions associated with human papillomavirus and human immunodeficiency virus. Anticancer Research 17:1281–1285
     [Google Scholar]
  2. Barillari G., Buonaguro L., Fiorelli V., Hoffman J., Michaels F., Gallo R. C., Ensoli B. 1992; Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Journal of Immunology 149:3727–3734
     [Google Scholar]
  3. Bernard H. U., Chan S. Y., Manos M. M., Hong C. K., Villa L. L., Delius H., Peyton L., Bauer H. M., Wheeler C. M. 1994; Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence and phylogenetic algorithms.. Journal of Infectious Diseases 170:1077–1085
     [Google Scholar]
  4. Chen M., Popescu N., Woodworth C., Bernerman Z., Corbellino M., Lusso P., Ablashi D. V., DiPaolo J. A. 1994; Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression.Journal of. Virology 68:1173–1178
     [Google Scholar]
  5. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162:156–159
     [Google Scholar]
  6. Contorni M., Leoncini P. 1993; Typing of human papillomavirus DNAs by restriction endonuclease mapping of the PCR products. Journal of Virological Methods 41:29–36
     [Google Scholar]
  7. Critchlow C. W., Hawes S. E., Kuypers J. M., Goldbaum G. M., Holmes K. K., Surawicz C. M., Kiviat N. B. 1998; Effect of HIV infection on the natural history of anal human papillomavirus infection.. AIDS 12:1177–1184
     [Google Scholar]
  8. Dolei A., Serra C., Arca M. V., Tilocca F., Pietravalle M., Alemanno L., Toniolo A., Ameglio F. 1994; Mutual interactions of HIV-1 and cytokines in adherent cells during acute infection.Archives of. Virology 134:157–168
     [Google Scholar]
  9. Dolei A., Serra C., Biolchini A., Serra C., Curreli S., Gomes E., Dianzani F. 1996; HIV-permissive cells from solid tissues: cytokine induction and effects.Perspectives in. Drugs Discovery and Design 5:90–101
     [Google Scholar]
  10. Dolei A., Biolchini A., Serra C., Curreli S., Gomes E., Dianzani F. 1998; Increased replication of T-cell- tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP- 1β and RANTES β-chemokines. AIDS 12:183–190
     [Google Scholar]
  11. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M. M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. 1994; Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma. Nature 371:674–680
     [Google Scholar]
  12. Fan J., Li P., Kok T. W., Burrell C. J. 1997; AZT blocks down- regulation of IL-2 and IFN-gamma gene expression in HIV acutely infected cells.Archives of. Virology 142:1035–1043
     [Google Scholar]
  13. Fauci A. S. 1996; Host factors and the pathogenesis of HIV-induced disease. Nature 384:529–534
     [Google Scholar]
  14. Felber B. K., Drysdale C. M., Pavlakis G. N. 1990; Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. Journal of Virology 64:3734–3741
     [Google Scholar]
  15. Flores E. R., Lambert P. F. 1997; Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the virus life cycle.Journal of. Virology 10:7167–7179
     [Google Scholar]
  16. Frattini M. G., Lim H. B., Doorbar J., Laimins L. A. 1997; Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. Journal of Virology 71:7068–7072
     [Google Scholar]
  17. Furuta Y., Eriksson K., Svennerholm B., Fredman P., Horal P., Jeansson S., Vahlne A., Holmgren J., Czerkinsky C. 1994; Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.. Proceedings of the National Academy of Sciences USA 91:12559–12563
     [Google Scholar]
  18. Gius D., Laimins L. A. 1989; Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and phorbol ester. Journal of Virology 63:555–563
     [Google Scholar]
  19. Goulsston C., McFarland W., Katzenstein D. 1998; Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases 177:1100–1103
     [Google Scholar]
  20. Harrington W., Sieczkowski L., Sosa C., Chan-a-Sue S., Cai J. P., Cabral L., Wood C. 1997; Activation of HHV-8 by HIV-1 Tat. Lancet 349:774–775
     [Google Scholar]
  21. Heard I., Schmitz V., Costagliola D., Orth G., Kazatchine M. D. 1998; Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12:1459–1464
     [Google Scholar]
  22. Heng M. C. Y., Heng S. Y., Allen S. G. 1994; Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343:255–258
     [Google Scholar]
  23. Hirka G., Prakash K., Kawashima H., Plotkin S. A., Andrews P. W., Gonczol E. 1991; Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection. Journal of Virology 65:2732–2735
     [Google Scholar]
  24. Hummel M., Lim H. B., Laimins L. A. 1995; Human papillomavirus type 31b late gene expression is regulated through protein kinase C- mediated changes in RNA processing. Journal of Virology 69:3381–3388
     [Google Scholar]
  25. Inagaki Y., Tsunokawa Y., Takebe N., Nawa H., Nakanishi S., Terada M., Sugimura T. 1988; Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells. Journal of Virology 62:1640–1646
     [Google Scholar]
  26. Ito M., Ishida T., He L., Tanabe F., Rongge Y., Miyakawa Y., Terunuma H. 1998; HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Research and Human Retroviruses 14:845–849
     [Google Scholar]
  27. Iversen A. K. N., Larsen A. R., Jensen T., Fugger L., Balslev U., Wahl S., Gerstoft J., Mullins J. L., Skinhoj J. 1998; Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. Journal of Infectious Diseases 177:1214–1220
     [Google Scholar]
  28. Jeon S., Allen-Hoffmann B. L., Lambert P. F. 1995; Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. Journal of Virology 69:2989–2997
     [Google Scholar]
  29. Kao S. Y., Calman A. F., Luciw P. A., Peterlin B. M. 1987; Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489–493
     [Google Scholar]
  30. Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O., Hakura A. 1994; Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200:130–139
     [Google Scholar]
  31. Levy J. A. 1994 HIV and the Pathogenesis of AIDS Washington, DC: American Society for Microbiology;
  32. Malim M. H., Cullen B. R. 1993; Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Molecular and Cellular Biology 13:6180–6189
     [Google Scholar]
  33. Melendy T., Sedman J., Stenlund A. 1995; Cellular factors required for papillomavirus DNA replication. Journal of Virology 69:7857–7867
     [Google Scholar]
  34. Meyers C., Mayer T. J., Ozbun M. A. 1997; Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. Journal of Virology 71:7381–7386
     [Google Scholar]
  35. Mostad S. B., Kreiss J. K. 1996; Shedding of HIV-1 in the genital tract. AIDS 10:1305–1315
     [Google Scholar]
  36. Palefsky J. M. 1997; Cutaneous and genital HPV-associated lesions in HIV-infected patients. Clinical Dermatology 15:439–447
     [Google Scholar]
  37. Popescu N. C., DiPaolo J. A., Amsbaugh S. C. 1987; Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenetics and Cell Genetics 44:58–62
     [Google Scholar]
  38. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  39. Schwarz E., Freese U. K., Gissman L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
     [Google Scholar]
  40. Six C., Heard I., Orth G., Poveda J. D., Zagury P., Cesbron P., Crenn-Hébert C., Pradinaud R., Sobesky M., Marty C., Babut M. L., Malkin J. E., Odier A., Fridmann S., Aubert J. P., Brunet J. B., de Vincenzi I., Bergeron I. 1998; Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 12:1047–1056
     [Google Scholar]
  41. Stoler M. H., Rhodes C. R., Whitebeck A., Wolinsky S. M., Chow L. T., Broker T. R. 1992; Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human Pathology 23:117–128
     [Google Scholar]
  42. Sun X. W., Kuhn L., Ellerbrock T. V., Chiasson M. A., Bush T. J., Wright T. C. 1997; Human papillomavirus infection in women infected with the human immunodeficiency virus. New England Journal of Medicine 337:1343–1349
     [Google Scholar]
  43. Tan W., Schwartz S. 1995; The rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region.Journal of. Virology 69:2932–2945
     [Google Scholar]
  44. Tan W., Felber B. K., Zolotukhin A. S., Pavlakis G. N., Schwartz S. 1995; Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis- acting transactivation element of simian retrovirus type 1. Journal of Virology 69:5607–5620
     [Google Scholar]
  45. Toniolo A., Serra C., Conaldi P. G., Basolo F., Falcone V., Dolei A. 1995; Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9:859–866
     [Google Scholar]
  46. Tornesello M. L., Buonaguro F. M., Giraldo E. B., Giraldo G. 1993; Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 36:57–64
     [Google Scholar]
  47. Vernon S. D., Hart C. E., Reeves W. C., Icenogle J. P. 1993; The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Research 27:133–145
     [Google Scholar]
  48. Vernon S. D., Zaki S. R., Reeves W. C. 1994; Localisation of HIV-1 to human papillomavirus associated cervical lesions.. Lancet 344:954–955
     [Google Scholar]
  49. Walz C., Deprez A., Dupressoir T., Durst M., Rabreau M., Schlehofer J. R. 1997; Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co- infecting human cervical epithelium. Journal of General Virology 78:1441–1452
     [Google Scholar]
  50. Woodworth C. D., McMullin E., Iglesias M., Plowman G. D. 1995; Interleukin α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.. Proceedings of the National Academy of Sciences USA 92:2840–2844
     [Google Scholar]
  51. Yang L., Morris G. F., Lockyer J. M., Lu M., Wang Z., Morris C. B. 1997; Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency type 1 transactivation by tat. Virology 235:48–64
     [Google Scholar]
  52. Zhao C., Tan W., Sokolowski M., Schwartz S. 1996; Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis -acting inhibitory sequence in the 3′ untranslated region of human papillomavirus type 1 late mRNAs. Journal of Virology 70:3659–3667
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-11-2937
Loading
Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein
J. Gen. Virol. 80, 2937 (1999); https://doi.org/10.1099/0022-1317-80-11-2937
/content/journal/jgv/10.1099/0022-1317-80-11-2937
/content/journal/jgv/10.1099/0022-1317-80-11-2937
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error